Regeneron and Roche Team Up to Triple Production of COVID-19 Treatment

Regeneron's (NASDAQ: REGN) COVID-19 treatment candidate is getting a big boost from Roche (OTC: RHHBY). The two companies announced in a joint press release Wednesday that they are collaborating on the development of the former's REGN-COV2, and will together manufacture and distribute it if it wins approval from regulators.

The pair said that by combining their efforts, the supply of the treatment could be ramped up by at least three and a half times current capacity. They added that there is potential for further increases.

Continue reading

Source Fool.com